The radioprotective activity has been studied of a new immunomodulatory lead material, Cumaside, which is a complex of monosulfated triterpene glycosides from the edible sea cucumber Cucumaria japonica and cholesterol. Female CD-1 strain mice administered with prophylactic doses of Cumaside were irradiated using a Gamma-therapeutic device with a 60 Co source (exposure dose 6.5 Gy, dose rate 1.14 Gy /min) and the average life span of the mice was determined. The animals administrated with Cumaside and irradiated were killed by pervisceral dislocation on days 4 and 9. Peripheral blood cell composition indexes, blood forming function and cell number in blood-forming organs and the number of pluripotent blood-forming stem cells were determined using standard procedures and the results compared with those of non-treated irradiated mice. The survivability percentage and average life span of the irradiated mice that were not treated with Cumaside were decreased in comparison with the Cumaside-treated groups. Especially, the leukocyte and neutrophil numbers in the blood (bone marrow from hip), and the weight and cell number of lymphoid organs were higher in the Cumaside-treated groups compared with the non-treated irradiated mice. It was concluded that at low prophylactic doses Cumaside possesses moderate radioprotective properties.
The number of individuals who receive a low dose of radiation during professional, diagnostic and therapeutic irradiation, and high doses of radiation in emergency situations is increasing significantly. Hence, studies concerning the search for effective anti-radiation agents (radioprotectors) having radioprophylactic and/or radiotherapeutic (curing) action are required. Special attention has been directed to the search for ways of protection against the effects of chronic irradiation by low intensive ionizing radiation in natural conditions. One of the most optimal pathways for this is use of biologically active substances of natural origin. Natural products that do not have a high protective action against strong irradiation compared with classic radioprotectors may be useful for protection against chronic irradiation. Because of either low toxicity or even lack of toxicity and good tolerance they may be used as either biologically active food supplements or drugs that may increase the general resistance of the organism due to stimulation of defensive functions, including antioxidant protection. Examples of these natural protective products are some adaptogens (including alkaloids, polysaccharides, triterpene glycosides and different compositions thereof), hemopoietic stimulators, estrogens, and immunomodulators that mobilize general organism resistance to diseases, including those caused by irradiation [1] [2] [3] [4] [5] .
Triterpene saponins (triterpene glycosides), composed of carbohydrate chains and a triterpene aglycon, are widely distributed in higher plants. Triterpene glycosides are characteristic of many sea cucumbers (Echinodermata: Holothurioidea) and some sponges (Porifera). Triterpene glycosides from sea cucumbers have lanostane type aglycons. Most contain lanostane aglycons with 18(20)lactones and belong to the so-called holostane series. The carbohydrate chains of sea cucumber glycosides are composed of two-six monosacchride residues, including xylose, quinovose, glucose, 3-O-methylglucose, and sometimes 3-O-methylxylose, 3-O-methylquinovose, 3-Omethylglucuronic acid, and 6-O-acetylglucose. They may contain one, two or three sulfate groups [6] [7] [8] [9] . Some glycosides from sea cucumbers show immunostimulatory effects at low concentrations. Incubation of immune cells with the glycosides induces their activation including sharp and reversible Са 2+ influx into cell cytoplasm, increase of macrophage lysosomal activity, ROS-formation in macrophages and an increase of phagocytic activity. Injection of subtoxic doses causes an increase in the number of antibody plaque-forming cells in the spleen, increasing the number, size and acidity of peritoneal macrophage lysosomes, phagocytic index of the cells in intraperitoneal exudates, and enhancement of the resistibility of experimental animals against different bacterial infections [10] [11] [12] [13] [14] .
The basis of the immunomodulatory action of sea cucumber triterpene glycosides cucumarioside A 2 -2 and frondoside A on mouse splenocytes is the regulation of expression of some proteins that participate in the formation of the cell immune response. Both glycosides regulate expression of proteins involved in the processes of maturation, activation and merging of lysosomes, phagocytosis, cytoskeleton rearrangement, cell adhesion, motility and proliferation of immune cells [15] .
Triterpene glycosides isolated from the edible sea cucumber Cucumaria japonica were used for the preparation of a new immunomodulatory lead material, Cumaside, which is a complex of monosulfated glycosides (preferably cucumarioside А 2 -2) with cholesterol [16] . Cumaside, in contrast with the glycoside itself, has no hemolytic activity at micro-and nano-molar concentrations, but stimulates lymphocytic lysosomal activity, ROS-formation in neutrophils, induction of cytokines (IL-6, INF-, TNF-α) and increases in the number of antibody plaque-forming cells forming in the spleen, restoration of the level of some CD-markers of human lymphocytes (CD3, CD4 and CD8) after preincubation of cells with hydrocortisone, enhancement of phagocytosis and bactericidal actions of human blood leukocytes, and significant increases in the resistance of mice against lethal doses of some pathogenic microorganisms, including Staphylococcus aureus and Yersinia pseudotuberculosis [17] . Recently, it was shown that Cumaside has pronounced antitumor activity against different forms of experimental mouse Ehrlich carcinoma in vivo both independently and in combination with 5-fluorouracil [27] .
The present article is a continuation of a series of investigations of Cumaside. The goal of this investigation was to study the radioprotective properties of Cumaside.
Effect of prophylactic Cumaside administration on survivability and average life span of sublethally irradiated mice:
Single stage, whole-body irradiation of CD-1 mice by gamma-radiation at a dose 6.5 Gy caused the death of all the experimental animals within 30 days, with an average life span of 15.2 days, as shown in Figure  1 and Table 1 . A single prophylactic administration of Cumaside four days before irradiation showed a positive radioprotective effect. The best results were obtained by administration of doses of 0.01 and 0.1 μg/kg. At these doses, the percentage survival of the irradiated mice was 20% compared with 0% in the control. The median survival was statistically higher in the animal groups treated with Cumaside at doses of 0.01 and 0.1 μg/kg than in the group treated with a dose of 1 μg/kg and the untreated group; it was calculated to be 23 days in the mouse groups with Cumaside administration of 0.01 and 0.1 g/kg compared with 15 days in the control group. The ALS of the remainder was found to be increased by 1.1 and 1.6 days in the Cumaside 0.1 and 0.01 μg/kg treated groups, respectively ( Table 1) .
Effect of prophylactic administration of Cumaside on hematopoiesis of irradiated mice:
The number of leukocytes and neutrophils decreased and the proportion of lymphocytes increased after irradiation (Control 2, irradiated mice) compared with the non-irradiated mice (Control 1, intact mice). Prophylactic Cumaside administration induced more rapid restoration of leukocyte and neutrophil numbers and an increase of relative and absolute number of lymphocytes.
Increases in leukocyte and neutrophil numbers were observed on the fourth and ninth day of the experiment. A significant recovery of leukocyte level was registered on the ninth day after irradiation of the mice given Cumaside doses of 0.01 and 0.1 μg/kg (p<0.05). The neutrophil concentration recovered significantly by the ninth day after irradiation of the mice dosed with 0.1 μg/kg Cumaside (p<0.05) ( Table 2) .
Radioactive irradiation caused a significant decrease in the weight of the immune system organs. The thymus weight of irradiated mice decreased six-fold and the spleen 3.3fold (Table 3 ). Prophylactic administration of Cumaside decreased the time for restoration to the normal level of the mass and cell number of the hematopoietic and lymphoid organs (thymus, spleen) of irradiated mice. Four and nine days after irradiation, all the doses of Cumaside resulted in significant increases in thymus weight. A significant increase in spleen weight occurred on day 4 at all applied doses ( Table 3 ). The number of cells in the thymus, spleen and marrow also decreased after irradiation compared with those of non-irradiated mice. A significant recovery of cell number in the thymus was not observed until the ninth day, while recovery in the spleen and marrow began on the fourth day. Significant changes in spleen cell number were recorded for almost all applied Cumaside doses on the fourth and ninth days, while the marrow cell number was increased significantly at a Cumaside dose of 0.1 g/kg only. The other doses showed a non-significant positive tendency in cell number increase ( Table 4 ).
Investigation of the effect of prophylactic administration of Cumaside on the number of pluripotent stem hematopoietic cells (PSHC) in the spleen of irradiated mice:
Single administration of Cumaside at a dose of 0.1 μg/kg four days before irradiation reliably increased the number of endogenic colonies in the spleen of sublethally irradiated mice from 22.0 ± 1.4 (in the control) to 26.9 ± 1.3 in the experimental group (Table 5 ). The other studied doses showed a tendency to increase the number of pluripotent stem hematopoietic cells (PSHC). An increase in PSHC forming endogenic colonies is critical for the survival of irradiated animals [20] .
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preventive action against radiation disease depends on the ability of the agent to limit hematopoietic tissue emptying that protects significant amounts of blood-forming elements and allows quick recovery of hematopoiesis with the help of intact or slightly damaged stem cells.
At lethal and sublethal irradiation, some known radioprotectors decrease mortality. So-called biological radioprotectors are substances of natural origin with different pharmacological properties (for example, adaptogenic, antioxidant, hemo-and immunostimulatory, and anti-mutagenic). As a rule, biological radioprotectors possess milder and long-term action, low or no toxicity, an ability to be administered orally, and effectiveness after irradiation. Some may restore the status of radiosensitive organs and systems. The radioprotective properties of these compounds may accompany the ability to stimulate the nonspecific resistance of organisms against infectious pathogens [22, 23] .
Some natural products may activate the protective resources of the organisms, acting on neurohumoral and immuno/hemopoietic regulatory systems. As a result, the general nonspecific resistance of an organism is increased and the endogenic background of radio-resistibility is stimulated. Endogenic biologically active compounds, including amines, thiols and other antioxidants have a protective function, at least partly, through suppressing an accumulation of an excess of the products of radioactive peroxide oxidation, which are harmful to living cells [24] .
Recently, interest in cytokines, polypeptides regulating growth, differentiation, functional activity and radioresistibility of cells, has greatly increased. The radioprotective action of cytokines is caused by their hemo-and immune-stimulatory activity and ability to increase the endogenic background of radioresistibility. One of the most important properties of cytokines is their ability to support increased radioresistance for several days. Interleukines that possess radioprotective properties include lymphokines, monokines, colony-stimulating factor and interferons. It is possible that at least one of the interleukines, interleukin-1β, may be used for quick antiradioactive therapy after emergency irradiation of humans. As a gene-engineering manufactured adaptogen and natural stimulator of immuno/hemopoesis, interleukin-1β is already used in medicine and is not a hazard for humans in effective doses [25] .
We have shown that prophylactic administration of an exogenic agent, Cumaside, affects positively indexes of cell contents of peripheral blood. It enhances a hematopoietic function, recovery of cell numbers in hematopoietic and lymphoid organs (thymus, spleen), as well as the number of pluripotent stem hematopoietic cells (PSHC), and increases survivability of lethally irradiated mice. It is possible that the basis of the preventive radioprotective, and the earlier studied immunomodulatory actions of Cumaside is the same (or similar) molecular mechanism that is linked with the ability to activate the proliferation of immune cells of mammalians and to induce the release of different cytokines (IL-6, INF-, TNF-) [17] . A similar conclusion concerning radioprotective activity has been made for ginseng preparations, including triterpene saponins of the dammarane series [26] .
The ability of Cumaside to provide quicker recovery of a hematopoietic function in the irradiated mice and its moderate radioprotective effect after prophylactic administration warrants further study of its effectiveness and probable medical application.
Experimental

Preparations:
The monosulfated triterpene glycoside cucumarioside А 2 -2, along with other minor related monosulfated glycosides, was isolated from the sea cucumber Cucumaria japonica, as described earlier [18] . Cumaside was obtained, using a patented procedure [16] , as a complex of monosulfated triterpene glycosides (preferably cucumarioside A 2 -2) with cholesterol in a 1: 2 molar ratio.
Irradiation of animals:
Female CD-1 strain mice weighing 18-20 g, obtained from the nursery of RAMS "Stolbovaya" (Russia), were used for the experiments. Upon receipt, the mice were housed, 5 per cage, and acclimatized for 2 weeks at a room temperature of 23°C. All the animals were maintained on a light schedule from 7:00 to 19:00 and were fed a standard mouse diet with water allowed ad libitum. Whole-body irradiation of the animals was carried out with a Gamma-therapeutic device [Rokus-M (Ravenstvo, Russia)] with a 60 Co source (exposure dose 6.5 Gy, dose rate 1.14 Gy /min). All experiments were conducted in compliance with the rules and international recommendations of the European Convention for the Protection of Vertebrate Animals used for experimental studies.
Investigation of influence of prophylactic administration of Cumaside on survivability and average life span of the irradiated mice:
For the experiments to determine survival rate following -irradiation, mice were grouped 10 per treatment group. Cumaside was suspended in 0.85 % NaCl solution and administered subcutaneously (SC) into the mice at doses of 0.01, 0.1 and 1.0 μg/kg. Single administration 4 days prior to irradiation was applied. The mice from the control group were injected subcutaneously with 0.85% NaCl solution. The animals were observed after Cumaside administration and irradiation, and survival was recorded daily for 30 days.
Investigation of influence of prophylactic administration of Cumaside on hemogenesis of irradiated mice:
For the experiments to determine hemogenesis of mice following -irradiation, mice were grouped 8 per treatment group.
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Cumaside suspension in 0.85% NaCl solution was administered subcutaneously (SC) into the mice. Single administration either 4 days prior to irradiation or fourfold every other day of administration (4, 3, 2 and 1 day before irradiation) at doses of 0.01, 0.1 or 1.0 μg/kg was applied depending on the experiment. After irradiation, mice were killed by pervisceral dislocation on days 4 and 9. Blood was collected from heart cavities and the leukocyte number counted with a hemocytometer. Simultaneously, a blood smear was prepared, fixed with methanol, stained with azure II-eosin, and the numbers of neutrophils and lymphocytes counted by microscopy. To evaluate the effect of Cumaside on weight and cell number of bloodforming (bone marrow) and lymphoid organs (thymus, spleen), the spleen and thymus were simultaneously dissected from the mice, homogenized and the homogenate filtered through a nylon filter. The number of nucleated cells was counted with a hemocytometer. Bone marrow was isolated from the femoral bone. The ephiphysis and diaphysis were separated, washed with 1 mL culture media 199 and the number of nucleated cells counted with a hemocytomter. To study the effect of prophylactic administration of Cumaside on the number of pluripotent stem hematopoietic cells (PSHC) in the spleen of sub-lethally irradiated mice, the spleen was isolated, immersed in Bouin's fixative and the number of discrete colonies of PSBFC counted using a standard procedure [20] .
Statistical analysis:
The Kaplan-Meier method was used for the estimation of mice survivability and median survival. Log-rank tests of survival curve were applied to estimate the significance on survival rate. Average life span (ALS) was calculated as the sum of the life span for all mice / total number of mice. Statistical analysis (t-test) of the hemogenesis data, including determination of means, standard errors, standard deviations and p-values, were evaluated using SigmaPlot 3.02 software (Jandel Scientific, San Rafael, CA).
